Joint Warfighter Medical Research Program Opportunity
April 25, 2024
The Joint Warfighter Medical Research Program (JWMRP) Broad Agency Announcement (BAA) has just opened. This program is designed to support the continuation of previously funded DOD medical research and development projects that align with current JWMRP focus areas. These funds, therefore, cannot be used for new projects or basic research.
FY24 JWMRP Focus Areas:
- Broad spectrum and/or pathogen agnostic approaches to prevent and/or treat endemic or emerging infectious diseases of high operational impact.
- Preventative capabilities to promote the Warfighter’s physiological and cognitive (1) performance and readiness and (2) injury prevention.
- Solutions for semi-autonomous or autonomous medical care from point of injury across the continuum of care.
- Virtual/telehealth and decision support with artificial intelligence solutions.
- Hemorrhage control and resuscitation solutions, including blood and blood products, and anti-shock therapeutics.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
